Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.

Suppr

超能文献

作者信息

Satler Lowell F

出版信息

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952.

DOI:10.1002/ccd.22952

PMID:21290554

Abstract

摘要

相似文献

Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952.

Drug eluting stents in CTOs: why not?

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):333-4. doi: 10.1002/ccd.22976.

Left main and high-risk PCI: what, exactly, is it high risk for?

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):952-3. doi: 10.1002/ccd.23208.

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.

EuroIntervention. 2011 Apr;6(9):1053-9. doi: 10.4244/EIJV6I9A184.

Drug-eluting stents: safe but not sufficient.

JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002.

If I've heard it once, I've heard it (not yet) a hundred times.

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):502. doi: 10.1002/ccd.22989.

Cobalt-chromium stenting in patients with acute myocardial infarction: thinner is better.

Catheter Cardiovasc Interv. 2011 Apr 1;77(5):615-6. doi: 10.1002/ccd.23069.

Another small step for small vessels.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):67-9. doi: 10.1002/ccd.22686.

Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion.

JACC Cardiovasc Interv. 2009 Dec;2(12):1266-8. doi: 10.1016/j.jcin.2009.10.007.

DES in SVGs: safe and at least short-term effective.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):356-7. doi: 10.1002/ccd.22972.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952.

Drug eluting stents in CTOs: why not?

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):333-4. doi: 10.1002/ccd.22976.

Left main and high-risk PCI: what, exactly, is it high risk for?

Catheter Cardiovasc Interv. 2011 Jun 1;77(7):952-3. doi: 10.1002/ccd.23208.

Relation between clopidogrel discontinuation and early cardiovascular events after percutaneous coronary intervention with drug-eluting stents.

EuroIntervention. 2011 Apr;6(9):1053-9. doi: 10.4244/EIJV6I9A184.

Drug-eluting stents: safe but not sufficient.

JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002.

If I've heard it once, I've heard it (not yet) a hundred times.

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):502. doi: 10.1002/ccd.22989.

Cobalt-chromium stenting in patients with acute myocardial infarction: thinner is better.

Catheter Cardiovasc Interv. 2011 Apr 1;77(5):615-6. doi: 10.1002/ccd.23069.

Another small step for small vessels.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):67-9. doi: 10.1002/ccd.22686.

Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion.

JACC Cardiovasc Interv. 2009 Dec;2(12):1266-8. doi: 10.1016/j.jcin.2009.10.007.

DES in SVGs: safe and at least short-term effective.

Catheter Cardiovasc Interv. 2011 Feb 15;77(3):356-7. doi: 10.1002/ccd.22972.